Outcome in dogs diagnosed with splenic hematomas

Differential diagnoses for a canine splenic mass include malignant tumors as well is benign masses including splenic hematoma and lymphoid hyperplasia. One study led to the development of the so-called two-thirds rule: approximately two-thirds of splenic masses will be malignant and two-thirds of those will be hemangiosarcomas (HSAs), the remaining one third of splenic masses would be expected to be benign. The most common benign splenic lesion reported in the dog is splenic hematoma. Canine splenic hematoma and HSA can have a similar clinical presentation and gross appearance at the time of surgery.
Source: Advances in Small Animal Medicine and Surgery - Category: Veterinary Research Tags: Oncology Source Type: research